Business Context and Reporting Period
Company: The Clorox Company
Filing Type: Form 8-K (Current Report)
Date of Report: August 21, 2017
Event Date: August 21, 2017 (Transaction Close)
This filing reports the completion of a strategic divestiture. On August 21, 2017, The Clorox Company closed the sale of its Aplicare skin antisepsis business.
Key Financial Metrics
The filing text does not provide specific financial values for revenue, profit, cash flow, margins, debt, or liquidity related to this transaction. The document serves as a notification of the event rather than a financial statement.
Material Changes
- Divestiture: The company sold the Aplicare skin antisepsis business.
- Closure: The transaction officially closed on August 21, 2017.
- Disclosure: A press release detailing the sale was issued on August 22, 2017, and is attached as Exhibit 99.1.
Guidance, Outlook, and Risks
The filing text does not contain updated financial guidance, management commentary on future outlook, specific risk factors, or details regarding contingencies and unusual items beyond the announcement of the sale.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 22, 2017) for the purchase price and specific terms of the Aplicare sale.
- Verify the impact of this divestiture on the company's future product portfolio and revenue streams in subsequent quarterly reports.
- Confirm if any gain or loss on the sale was recognized in the financial statements for the quarter ending August 2017.